Arkolith/Insider Trading/TARS/Form 4

Azamian Bobak R.

President/CEO and Board Chair, DirectorTarsus Pharmaceuticals, Inc. (TARS) · full profile →Form 4 · filed Mar 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.4M
Net Open-Market Flow
-$2.4M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 19, 2026Sell(S)12K$67.00$802K33K
Mar 18, 2026Sell(S)12K$68.71$802K45K
Mar 17, 2026Sell(S)11K$69.42$762K57K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001827672-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML